A Randomized Phase II Trial of Docetaxel or Cabazitaxel With or Without Darolutamide in Men With Metastatic Castration-resistant Prostate Cancer
Latest Information Update: 11 Jul 2024
At a glance
- Drugs Darolutamide (Primary) ; Cabazitaxel
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms DAROTAXEL
Most Recent Events
- 16 Oct 2023 Planned initiation date changed from 1 May 2023 to 19 Oct 2023.
- 16 Oct 2023 Status changed from not yet recruiting to recruiting.
- 13 Mar 2023 New trial record